Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 914026, 6 pages
http://dx.doi.org/10.1155/2015/914026
Research Article

Lentiviral-Mediated Silencing of Farnesyl Pyrophosphate Synthase through RNA Interference in Mice

Institute of Cardiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China

Received 23 May 2014; Revised 6 December 2014; Accepted 2 January 2015

Academic Editor: Min Li

Copyright © 2015 Jian Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Räikkönen, H. Mönkkönen, S. Auriola, and J. Mönkkönen, “Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells,” Biochemical Pharmacology, vol. 79, no. 5, pp. 777–783, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. G. P. Eckert, G. P. Hooff, D. M. Strandjord et al., “Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients,” Neurobiology of Disease, vol. 35, no. 2, pp. 251–257, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Wang, A. Panasiuk, and D. W. Grainger, “Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures,” Molecular Pharmaceutics, vol. 8, no. 4, pp. 1016–1024, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Ye, Y. Mou, B. Bai, L. Li, G. P. Chen, and S. J. Hu, “Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy,” International Journal of Biochemistry and Cell Biology, vol. 42, no. 12, pp. 2056–2064, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Han, D.-M. Jiang, C.-Q. Du, and S.-J. Hu, “Alteration of enzyme expressions in mevalonate pathway: possible role for cardiovascular remodeling in spontaneously hypertensive rats,” Circulation Journal, vol. 75, no. 6, pp. 1409–1417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Yang, Y. Mou, T. Wu et al., “Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice,” Cardiovascular Research, vol. 97, no. 3, pp. 490–499, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Pfeifer, M. Ikawa, Y. Dayn, and I. M. Verma, “Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 4, pp. 2140–2145, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Pfeifer, S. Eigenbrod, S. Al-Khadra et al., “Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice,” Journal of Clinical Investigation, vol. 116, no. 12, pp. 3204–3210, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Raoul, T. Abbas-Terki, J.-C. Bensadoun et al., “Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS,” Nature Medicine, vol. 11, no. 4, pp. 423–428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Caton, A. Calabrese, C. Mas et al., “Lentivirus-mediated transduction of connexin cDNAs shows level- and isoform-specific alterations in insulin secretion of primary pancreatic β-cells,” Journal of Cell Science, vol. 116, no. 11, pp. 2285–2294, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Yang, J.-C. Jiang, L. Guo, and S.-J. Hu, “Establishment of transgenic mice carrying the gene for farnesyl pyrophosphate synthase,” Biotechnology Letters, vol. 33, no. 4, pp. 687–692, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. Q. Kong, M. Wu, Y. Huan et al., “Transgene expression is associated with copy number and cytomegalovirus promoter methylation in transgenic pigs,” PLoS ONE, vol. 4, no. 8, Article ID e6679, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Li, G.-P. Chen, Y. Yang, Y. Ye, L. Yao, and S.-J. Hu, “Chronic inhibition of farnesyl pyrophosphate synthase attenuates cardiac hypertrophy and fibrosis in spontaneously hypertensive rats,” Biochemical Pharmacology, vol. 79, no. 3, pp. 399–406, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Ye, S. J. Hu, and L. Li, “Inhibition of farnesylpyrophosphate synthase prevents angiotensin II-induced hypertrophic responses in rat neonatal cardiomyocytes: involvement of the RhoA/Rho kinase pathway,” FEBS Letters, vol. 583, no. 18, pp. 2997–3003, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Yang, H.-H. Zhu, G.-P. Chen et al., “Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo,” International Journal of Biochemistry and Cell Biology, vol. 45, no. 3, pp. 657–666, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. G. P. Chen, L. Li, Y. Yang et al., “Chronic inhibition of farnesyl pyrophosphate synthase improves endothelial function in spontaneously hypertensive rats,” Biochemical Pharmacology, vol. 80, no. 11, pp. 1684–1689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. G. G. Russell, “Bisphosphonates: the first 40 years,” Bone, vol. 49, no. 1, pp. 2–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Y.-Q. Su, K. Sugiura, K. Wigglesworth et al., “Oocyte regulation of metabolic cooperativity between mouse cumulus cells and oocytes: BMP15 and GDF9 control cholesterol biosynthesis in cumulus cells,” Development, vol. 135, no. 1, pp. 111–121, 2008. View at Publisher · View at Google Scholar · View at Scopus